David R. Karp

10.1k total citations · 2 hit papers
153 papers, 6.2k citations indexed

About

David R. Karp is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David R. Karp has authored 153 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 41 papers in Rheumatology and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David R. Karp's work include Systemic Lupus Erythematosus Research (37 papers), Monoclonal and Polyclonal Antibodies Research (28 papers) and T-cell and B-cell Immunology (27 papers). David R. Karp is often cited by papers focused on Systemic Lupus Erythematosus Research (37 papers), Monoclonal and Polyclonal Antibodies Research (28 papers) and T-cell and B-cell Immunology (27 papers). David R. Karp collaborates with scholars based in United States, Canada and China. David R. Karp's co-authors include Nancy J. Olsen, Eric O. Long, Edward K. Wakeland, V. Michael Holers, Irving Kushner, Peter E. Lipsky, Donald C. Shreffler, Susan A. Boackle, Valerie Klusas Branch and Chandra Mohan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David R. Karp

150 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1

2020 345 citations Lauren A. Henderson, Scott Canna et al. Arthritis & Rheumatology profile →
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3

2022 150 citations Lauren A. Henderson, Scott Canna et al. Arthritis & Rheumatology profile →

Peers

Countries citing papers authored by David R. Karp

Since Specialization

Citations

This map shows the geographic impact of David R. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Karp more than expected).

Fields of papers citing papers by David R. Karp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Karp. The network helps show where David R. Karp may publish in the future.

Co-authorship network of co-authors of David R. Karp

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Karp. A scholar is included among the top collaborators of David R. Karp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Karp. David R. Karp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity 2025 ·Lupus Science & Medicine ·Melissa E. Munroe, Kendra A. Young, Rufei Lu, Joel M. Guthridge, Diane L. Kamen, Gary S. Gilkeson, Michael H. Weisman, Mariko Ishimori, Daniel J. Wallace, David R. Karp, George C. Tsokos, Michael P. Keith, John B. Harley, Jill M. Norris, Judith A. James	1
2	A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus 2025 ·Arthritis & Rheumatology ·Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane L. Kamen, (unknown), Daniel J. Wallace, Christopher C. Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Élise Schaefer, Vernon M. Chinchilli, David R. Karp	0
3	Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events 2023 ·JAMA Network Open ·Yu Zuo, Sherwin Navaz, Wenying Liang, Chun Li, Colby Ayers, (unknown), Alyssa Harbaugh, Gary L. Norman, E. Blair Solow, Bonnie L. Bermas, (unknown), Anand Rohatgi, David R. Karp, Jason S. Knight, James A. de Lemos	16
4	A Rare Case: Acute Liver Injury Uncovering a Diagnosis of B-cell Acute Lymphoblastic Leukemia in a Young Adult 2023 ·Cureus ·(unknown), David R. Karp, (unknown), (unknown)	1
5	Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know 2022 ·Current Rheumatology Reports ·Elena K. Joerns, Traci N. Adams, Jeffrey A. Sparks, Chad A. Newton, (unknown), David R. Karp, Una E. Makris	3
6	SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity 2020 ·American Journal of Clinical Pathology ·William S. Phipps, Jeffrey A. SoRelle, Quan‐Zhen Li, Lenin Mahimainathan, Ellen Araj, (unknown), Chantale Lacelle, Jyoti Balani, (unknown), E. Blair Solow, David R. Karp, Ravi Sarode, Alagarraju Muthukumar	46
7	American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 2020 ·Arthritis & Rheumatology ·Lauren A. Henderson, Scott Canna, Kevin G. Friedman, Mark Gorelik, Sivia Lapidus, Hamid Bassiri, Edward M. Behrens, Anne Ferris, Kate F. Kernan, Grant S. Schulert, Philip Seo, Mary Beth F. Son, Adriana H. Tremoulet, Rae S. M. Yeung, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay Mehta	263
8	American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 breakdown → 2020 ·Arthritis & Rheumatology ·Lauren A. Henderson, Scott Canna, Kevin G. Friedman, Mark Gorelik, Sivia Lapidus, Hamid Bassiri, Edward M. Behrens, Anne Ferris, Kate F. Kernan, Grant S. Schulert, Philip Seo, Mary Beth F. Son, Adriana H. Tremoulet, Rae S. M. Yeung, Amy S. Mudano, Amy S. Turner, David R. Karp, Jay Mehta	345
9	Student conduct, restorative justice, and student development: findings from the STARR project: a student accountability and restorative research project 2014 ·Contemporary Justice Review ·David R. Karp, (unknown)	22
10	Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates 2013 ·Journal of Immunological Methods ·Jiexia Quan, (unknown), M. Muralidhar Reddy, (unknown), Quan‐Zhen Li, Dwight C. German, Nancy J. Olsen, Thomas Kodadek, David R. Karp	16
11	Toward an ontology-based framework for clinical research databases 2010 ·Journal of Biomedical Informatics ·Yuyao Kong, (unknown), Qun Xiang, Qian Yu, David R. Karp, Richard H. Scheuermann	26
12	HLA genetic association analysis using the sequence feature variant type approach (136.31) 2009 ·The Journal of Immunology ·Nishanth Marthandan, David R. Karp, Frank C. Arnett, Matthew Waller, (unknown), Michael Feolo, Steven G. E. Marsh, Richard H. Scheuermann	1
13	Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus 2007 ·Annals of the Rheumatic Diseases ·Amr H. Sawalha, Kenneth M. Kaufman, Jennifer A. Kelly, Adam J. Adler, Teresa Aberle, J Kilpatrick, Edward K. Wakeland, Q-Z Li, Amy E. Wandstrat, David R. Karp, Judith A. James, Joan T. Merrill, Peter E. Lipsky, John B. Harley	146
14	Volunteer Management in Boards of Probation 2007 ·Journal of Offender Rehabilitation ·(unknown), David R. Karp	1
15	Oxidative Stress Promotes Polarization of Human T Cell Differentiation Toward a T Helper 2 Phenotype 2006 ·The Journal of Immunology ·(unknown), (unknown), Laurie S. Davis, David R. Karp	100
16	Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement 2005 ·The Journal of Immunology ·Youngkyun Lee, Karen M. Haas, Dennis O. Gor, Xuedong Ding, David R. Karp, Neil S. Greenspan, Jonathan C. Poe, Thomas F. Tedder	39
17	Cutting Edge: C3d Functions as a Molecular Adjuvant in the Absence of CD21/35 Expression 2004 ·The Journal of Immunology ·Karen M. Haas, Franklin R. Toapanta, Julie A. Oliver, Jonathan C. Poe, John H. Weis, David R. Karp, Joseph Bower, Ted M. Ross, Thomas F. Tedder	55
18	What is Community Justice?: Case Studies of Restorative Justice and Community Supervision 2002 ·David R. Karp, Todd R. Clear	23
19	Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. 1992 ·The Journal of Experimental Medicine ·Ned Braunstein, Dominique A. Weber, (unknown), Eric O. Long, David R. Karp	27
20	Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. 1992 ·The Journal of Experimental Medicine ·David R. Karp, Eric O. Long	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact